Table 1 Baseline patient characterictics
From: Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
Baseline | All patients (n = 150) | Adverse outcome (n = 17) | No adverse outcome (n = 133) | p-value |
|---|---|---|---|---|
Females | 66 (44) | 6 (35) | 60 (45) | 0.45 |
History of CAD | 45 (30) | 9 (53) | 36 (27) | 0.06 |
History of CHF | 24 (16) | 6 (35) | 18 (14) | 0.10 |
History of smoking | 53 (35) | 10 (59) | 43 (32) | 0.06 |
Diabetes mellitus | 44 (29) | 9 (53) | 35 (226) | 0.06 |
Hypertension | 90 (60) | 15 (88) | 75 (56) | 0.01 |
Hyperlipidemia | 111 (74) | 13 (76) | 98 (74) | 0.88 |
Stroke | 10 (7) | 1 (6) | 9 (7) | 0.93 |
Peripheral vascular disease | 7 (5) | 2 (12) | 5 (4) | 0.35 |
LVEF (%) | 58.0 ± 11.7 | 50.1 ± 16.6 | 59.5 ± 10.5 | 0.04 |
BMI (kg/m2) | 29.0 ± 7.0 | 25.2 ± 9.50 | 29.0 ± 6.3 | 0.13 |
Age (years) | 56.0 ± 14.7 | 65.9 ± 10.8 | 54.4 ± 14.6 | 0.01 |